Scientific Publications

Clinical characterization and ancillary tests in Susac syndrome: a systematic review

A. Wilf-Yarkoni
O. Zmira
A. Tolkovsky
B. Pflantzer
S.G. Gofrit
I. Kleffner
F. Paul
J. Dörr

Polyglutamine disease proteins: Commonalities and differences in interaction profiles and pathological effects

M. Bonsor
O. Ammar
S. Schnoegl
E.E. Wanker
E. Silva Ramos

Improving the sensitivity of myelin oligodendrocyte glycoprotein-antibody testing: exclusive or predominant MOG-IgG3 seropositivity - a potential diagnostic pitfall in patients with MOG-EM/MOGAD

S. Jarius
M. Ringelstein
K. Schanda
K. Ruprecht
M. Korporal-Kuhnke
A. Viehöver
M.W. Hümmert
P. Schindler
V. Endmayr
M. Gastaldi
C. Trebst
D. Franciotta
O. Aktas
R. Höftberger
J. Haas
L. Komorowski
F. Paul
M. Reindl
B. Wildemann

External mechanical stability regulates hematoma vascularization in bone healing rather than endothelial YAP/TAZ mechanotransduction

J. Mehl
S.K. Farahani
E. Brauer
A. Klaus-Bergmann
T. Thiele
A. Ellinghaus
E. Bartels-Klein
K. Koch
K. Schmidt-Bleek
A. Petersen
H. Gerhardt
V. Vogel
G.N. Duda

AI-guided pipeline for protein-protein interaction drug discovery identifies an SARS-CoV-2 inhibitor

P. Trepte
C. Secker
J. Olivet
J. Blavier
S. Kostova
S.B. Maseko
I. Minia
E. Silva Ramos
P. Cassonnet
S. Golusik
M. Zenkner
S. Beetz
M.J. Liebich
N. Scharek
A. Schutz
M. Sperling
M. Lisurek
Y. Wang
K. Spirohn
T. Hao
M.A. Calderwood
D.E. Hill
M. Landthaler
S.G. Choi
J.C. Twizere
M. Vidal
E.E. Wanker

April 01, 2024 / Ann Neurol

Time to disability milestones and annualized relapse rates in NMOSD and MOGAD

A. Duchow
J. Bellmann-Strobl
T. Friede
O. Aktas
K. Angstwurm
I. Ayzenberg
A. Berthele
E. Dawin
D. Engels
K. Fischer
M. Flaskamp
K. Giglhuber
M. Grothe
J. Havla
M.W. Hümmert
S. Jarius
M. Kaste
P. Kern
I. Kleiter
L. Klotz
M. Korporal-Kuhnke
M. Kraemer
M. Krumbholz
T. Kümpfel
L. Lohmann
M. Ringelstein
P. Rommer
P. Schindler
C. Schubert
C. Schwake
M. Senel
F.T. Bergh
D. Tkachenko
H. Tumami
C. Trebst
I. Vardakas
A. Walter
C. Warnke
M.S. Weber
J. Wickel
B. Wildemann
A. Winkelmann
F. Paul
J.P. Stellmann
V. Häußler

Body mass, neuro-hormonal stress processing, and disease activity in lean to obese people with multiple sclerosis

L. Meyer-Arndt
J. Brasanac
S. Gamradt
J. Bellmann-Strobl
L. Maurer
K. Mai
T. Steward
J. Spranger
T. Schmitz-Hübsch
F. Paul
S.M. Gold
M. Weygandt

CD4+ T cell mitochondrial genotype in Multiple Sclerosis: a cross-sectional and longitudinal analysis

F. Cortes-Figueiredo
S. Asseyer
C. Chien
H.G. Zimmermann
K. Ruprecht
T. Schmitz-Hübsch
J. Bellmann-Strobl
F. Paul
V.A. Morais

The T1-weighted/T2-weighted ratio as a biomarker of anti-NMDA receptor encephalitis

T.J. Hartung
G. Cooper
V. Jünger
D. Komnenić
L. Ryan
J. Heine
C. Chien
F. Paul
H. Prüss
C. Finke

The paradigm change from reactive medical services to 3PM in ischemic stroke: a holistic approach utilising tear fluid multi-omics, mitochondria as a vital biosensor and AI-based multi-professional data interpretation

O. Golubnitschaja
J. Polivka
P. Potuznik
M. Pesta
I. Stetkarova
A. Mazurakova
L. Lackova
P. Kubatka
M. Kropp
G. Thumann
C. Erb
H. Fröhlich
W. Wang
B. Baban
M. Kapalla
N. Shapira
K. Richter
A. Karabatsiakis
I. Smokovski
L.C. Schmeel
E. Gkika
F. Paul
P. Parini
J. Polivka